Imperagen Taps Quantum Physics and AI to Overhaul Enzyme Engineering
Biotech startup Imperagen secures £5 million in seed funding to replace trial-and-error lab work with quantum simulations and closed-loop AI models.
Biotech startup Imperagen secures £5 million in seed funding to replace trial-and-error lab work with quantum simulations and closed-loop AI models.